Iron deficiency in patients with heart failure - Wikidata - wikimedia - TriplyDB

Iron deficiency in patients with heart failure

Iron deficiency in patients with heart failure

http://www.wikidata.org/entity/Q26822876

about

Towards Holistic Heart Failure Management-How to Tackle the Iron Deficiency Epidemic?Iron in kidney and heart failure: from theory to practice.5th International multidisciplinary course on iron anemia, 31st March-1 April 2017, Florence, Italy.

P2860

Q39409288-49D83E15-1257-44DB-B17B-AE31F3E63171 Q48306942-0A8B1933-8125-48C2-9C37-D46968D57DDE Q48564707-39BA8DDE-575C-4CDF-ABD8-528F6EE0B319

P2860

Iron deficiency in patients with heart failure

http://www.wikidata.org/entity/Q26822876

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Iron deficiency in patients with heart failure

@ast

Iron deficiency in patients with heart failure

@en

Iron deficiency in patients with heart failure

@nl

type

label

Iron deficiency in patients with heart failure

@ast

Iron deficiency in patients with heart failure

@en

Iron deficiency in patients with heart failure

@nl

prefLabel

Iron deficiency in patients with heart failure

@ast

Iron deficiency in patients with heart failure

@en

Iron deficiency in patients with heart failure

@nl

P1433

Q26822876-52AE9128-07D2-4E1D-A295-9F457CFF0443

P1476

Q26822876-31D73AA9-5895-43EE-A016-08D63F209D91

P2093

Q26822876-9D258915-2A7F-424E-8A3D-FD07F353A2E5

Q26822876-A5D98B06-E35D-4544-A561-B33F2CCB0798

P2860

Q26822876-0959C823-134E-43E6-AA57-2B600CE8D33F

Q26822876-0EBCF965-41F0-4DE9-AC7C-339EB9FBF237

Q26822876-128FE937-2031-4013-AFAC-F0652C0347C0

Q26822876-189088E9-9C4C-41C6-B65A-6E11135DE24E

Q26822876-192DBE33-CCEA-4245-87E0-D0FB72372A0C

Q26822876-315B9F8C-D74B-47D6-94B6-DC706CA7E983

Q26822876-35DFD7D5-AF90-4C62-9E8B-A9E1F5050CA8

Q26822876-3A75E961-612D-44CC-A2F3-97632CEB7DBC

Q26822876-3AD40993-49AD-4E38-BEE5-85F6EC342932

Q26822876-4CA9BB16-57F8-4A11-9ED6-F52777F4C8E6

P304

Q26822876-42EE65C3-C06C-43F6-AAD2-6CF9D858D8C9

P31

Q26822876-46C0178F-D93E-4718-B930-1D2992F834B8

P356

Q26822876-57D6C968-F96C-4290-A672-1DE1D421D1F6

P407

Q26822876-B30AD46C-696A-42F2-96F8-C1FE16813406

P433

Q26822876-01B8F9A2-979A-4B1F-9C2D-A9BC68F64030

P478

Q26822876-3944B9EB-46F0-4C97-B237-66DEC4A6B023

P577

Q26822876-EB916663-9821-4769-AB02-5FC5CFA9432F

P5875

Q26822876-25DD9E38-34C9-4A6C-A3AC-9B2D7A0B7521

P698

Q26822876-F7B7B0CC-C2EC-4DFB-B220-3A2CDAB30B76

P921

Q26822876-B8AAA076-82E0-44BD-9AC5-4ABA65EB47F2

P356

P1433

European heart journal. Cardiovascular pharmacotherapy

P1476

Iron deficiency in patients with heart failure

@en

P2093

Robert Neil Doughty

http://www.w3.org/2001/XMLSchema#string

Sarah Fitzsimons

http://www.w3.org/2001/XMLSchema#string

P2860

Health related quality of life in patients with congestive heart failure: comparison with other chronic diseases and relation to functional variables

Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation

Hepcidin, a putative mediator of anemia of inflammation, is a type II acute-phase protein

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the

Decreasing one-year mortality and hospitalization rates for heart failure in Sweden; Data from the Swedish Hospital Discharge Registry 1988 to 2000.

The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis.

Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency†.

Anemia of chronic disease.

Exercise and heart failure: A statement from the American Heart Association Committee on exercise, rehabilitation, and prevention.

The effect of intravenous ferric carboxymaltose on health-related quality of life in patients with chronic heart failure and iron deficiency: a subanalysis of the FAIR-HF study.

P304

58-64

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/EHJCVP/PVU016

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

1

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283165723

http://www.w3.org/2001/XMLSchema#string

P698

27533968

http://www.w3.org/2001/XMLSchema#string

P921